Anesth Analg:机械通气模式不影响脊柱手术中的失血或输血要求:回顾性研究

2020-01-28 背景与目的 “罂粟花”微信号

成人脊柱畸形手术失血是多种因素影响的结局。麻醉相关的机械通通气方式可导致术中失血。本研究旨在探讨通气模式及呼吸参数对俯卧位脊柱手术患者术中失血量及输血需求的影响。

背景与目的

成人脊柱畸形手术失血是多种因素影响的结局。麻醉相关的机械通通气方式可导致术中失血。本研究旨在探讨通气模式及呼吸参数对俯卧位脊柱手术患者术中失血量及输血需求的影响。

方  法

这项单中心回顾性研究纳入了2015年5月至2016年6月期间接受择期俯卧位脊柱手术的18岁以上患者的电子病历。通气模式和呼吸参数与术中估计失血量(EBL)的关系,其包括浓缩红细胞(PRBCs)、新鲜冰冻血浆(FFP)、冷沉淀和血小板输注,采用多元线性回归模型对年龄、性别、ASA分级、体重指数(BMI)、术前凝血参数和实验室数值、手术水平、支架结构、截骨术、经孔腰椎间融合术、椎板切除术、再手术、脊柱手术侵入指数和手术时间进行分析。在二次分析中,比较了压力控制通气(PCV)和容积控制通气(VCV)倾向评分匹配队列的术中估计失血量(EBL)、输血量和术后引流量的关系。

结 果

回顾了946份记录,并将822份记录纳入分析。调整复杂因素后,未观察到通气模式和术中EBL(估计值 -2;95%置信区间[CI],-248至245;P=0.99)或血制品输注之间差异具有统计意义(PRBC:估计值 -9;95%CI,-154至135;P=0.90;FFP:估计值 -3;95%CI,-59至54;P=0.93;冷沉淀:估计值 -14;95%CI,-70至43;P=0.63;血小板:-7;95%CI,-39至24;P=0.64)。在倾向性评分匹配后,PCV组和VCV组在EBL(平均差525ml;95%CI,-15至1065;P=0.056)和输血方面(PRBC:平均差 208mL;95%CI,-23至439;P=0.077;FFP:平均差34mL;95%CI,-17至84;P=。19;冷冻沉淀:平均差55mL;95%CI,-24至133;P=。17)或血小板:平均差26mL;95%CI,-12-64;P=。18)都无显着性差异。

结 论

在俯卧位脊柱手术中,机械通气模式和气道压力与术中失血或需要异体输血无关。

原始出处:

Lauren K. Dunn,  Davis G. Taylor,  Ching-Jen Chen, Priyanka Singla, MBBS.et al.Ventilator Mode Does Not Influence Blood Loss or Transfusion Requirements During Major Spine Surgery:A Retrospective Study.Anesth Analg 2020;130:100–10.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1654233, encodeId=5a77165423327, content=<a href='/topic/show?id=58408453394' target=_blank style='color:#2F92EE;'>#脊柱手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84533, encryptionId=58408453394, topicName=脊柱手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63bb24475410, createdName=xuruicheng, createdTime=Tue Mar 31 14:24:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051507, encodeId=3ea2205150e57, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Mar 12 08:24:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633555, encodeId=a54b163355519, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Mon Mar 02 10:24:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700112, encodeId=de171e0011253, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sat Feb 22 20:24:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259723, encodeId=cbdb1259e2399, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522669, encodeId=36a81522669bd, content=<a href='/topic/show?id=4c364430828' target=_blank style='color:#2F92EE;'>#失血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44308, encryptionId=4c364430828, topicName=失血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c011466504, createdName=daviiliu, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585698, encodeId=14cb1585698c7, content=<a href='/topic/show?id=e76840556f9' target=_blank style='color:#2F92EE;'>#回顾性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40556, encryptionId=e76840556f9, topicName=回顾性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037917278808, createdName=jiyangfei, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1654233, encodeId=5a77165423327, content=<a href='/topic/show?id=58408453394' target=_blank style='color:#2F92EE;'>#脊柱手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84533, encryptionId=58408453394, topicName=脊柱手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63bb24475410, createdName=xuruicheng, createdTime=Tue Mar 31 14:24:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051507, encodeId=3ea2205150e57, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Mar 12 08:24:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633555, encodeId=a54b163355519, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Mon Mar 02 10:24:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700112, encodeId=de171e0011253, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sat Feb 22 20:24:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259723, encodeId=cbdb1259e2399, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522669, encodeId=36a81522669bd, content=<a href='/topic/show?id=4c364430828' target=_blank style='color:#2F92EE;'>#失血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44308, encryptionId=4c364430828, topicName=失血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c011466504, createdName=daviiliu, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585698, encodeId=14cb1585698c7, content=<a href='/topic/show?id=e76840556f9' target=_blank style='color:#2F92EE;'>#回顾性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40556, encryptionId=e76840556f9, topicName=回顾性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037917278808, createdName=jiyangfei, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1654233, encodeId=5a77165423327, content=<a href='/topic/show?id=58408453394' target=_blank style='color:#2F92EE;'>#脊柱手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84533, encryptionId=58408453394, topicName=脊柱手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63bb24475410, createdName=xuruicheng, createdTime=Tue Mar 31 14:24:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051507, encodeId=3ea2205150e57, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Mar 12 08:24:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633555, encodeId=a54b163355519, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Mon Mar 02 10:24:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700112, encodeId=de171e0011253, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sat Feb 22 20:24:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259723, encodeId=cbdb1259e2399, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522669, encodeId=36a81522669bd, content=<a href='/topic/show?id=4c364430828' target=_blank style='color:#2F92EE;'>#失血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44308, encryptionId=4c364430828, topicName=失血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c011466504, createdName=daviiliu, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585698, encodeId=14cb1585698c7, content=<a href='/topic/show?id=e76840556f9' target=_blank style='color:#2F92EE;'>#回顾性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40556, encryptionId=e76840556f9, topicName=回顾性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037917278808, createdName=jiyangfei, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=)]
    2020-03-02 AspirantSuo
  4. [GetPortalCommentsPageByObjectIdResponse(id=1654233, encodeId=5a77165423327, content=<a href='/topic/show?id=58408453394' target=_blank style='color:#2F92EE;'>#脊柱手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84533, encryptionId=58408453394, topicName=脊柱手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63bb24475410, createdName=xuruicheng, createdTime=Tue Mar 31 14:24:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051507, encodeId=3ea2205150e57, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Mar 12 08:24:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633555, encodeId=a54b163355519, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Mon Mar 02 10:24:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700112, encodeId=de171e0011253, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sat Feb 22 20:24:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259723, encodeId=cbdb1259e2399, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522669, encodeId=36a81522669bd, content=<a href='/topic/show?id=4c364430828' target=_blank style='color:#2F92EE;'>#失血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44308, encryptionId=4c364430828, topicName=失血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c011466504, createdName=daviiliu, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585698, encodeId=14cb1585698c7, content=<a href='/topic/show?id=e76840556f9' target=_blank style='color:#2F92EE;'>#回顾性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40556, encryptionId=e76840556f9, topicName=回顾性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037917278808, createdName=jiyangfei, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=)]
    2020-02-22 经常头晕
  5. [GetPortalCommentsPageByObjectIdResponse(id=1654233, encodeId=5a77165423327, content=<a href='/topic/show?id=58408453394' target=_blank style='color:#2F92EE;'>#脊柱手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84533, encryptionId=58408453394, topicName=脊柱手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63bb24475410, createdName=xuruicheng, createdTime=Tue Mar 31 14:24:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051507, encodeId=3ea2205150e57, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Mar 12 08:24:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633555, encodeId=a54b163355519, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Mon Mar 02 10:24:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700112, encodeId=de171e0011253, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sat Feb 22 20:24:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259723, encodeId=cbdb1259e2399, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522669, encodeId=36a81522669bd, content=<a href='/topic/show?id=4c364430828' target=_blank style='color:#2F92EE;'>#失血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44308, encryptionId=4c364430828, topicName=失血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c011466504, createdName=daviiliu, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585698, encodeId=14cb1585698c7, content=<a href='/topic/show?id=e76840556f9' target=_blank style='color:#2F92EE;'>#回顾性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40556, encryptionId=e76840556f9, topicName=回顾性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037917278808, createdName=jiyangfei, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=)]
    2020-01-30 windight
  6. [GetPortalCommentsPageByObjectIdResponse(id=1654233, encodeId=5a77165423327, content=<a href='/topic/show?id=58408453394' target=_blank style='color:#2F92EE;'>#脊柱手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84533, encryptionId=58408453394, topicName=脊柱手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63bb24475410, createdName=xuruicheng, createdTime=Tue Mar 31 14:24:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051507, encodeId=3ea2205150e57, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Mar 12 08:24:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633555, encodeId=a54b163355519, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Mon Mar 02 10:24:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700112, encodeId=de171e0011253, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sat Feb 22 20:24:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259723, encodeId=cbdb1259e2399, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522669, encodeId=36a81522669bd, content=<a href='/topic/show?id=4c364430828' target=_blank style='color:#2F92EE;'>#失血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44308, encryptionId=4c364430828, topicName=失血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c011466504, createdName=daviiliu, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585698, encodeId=14cb1585698c7, content=<a href='/topic/show?id=e76840556f9' target=_blank style='color:#2F92EE;'>#回顾性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40556, encryptionId=e76840556f9, topicName=回顾性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037917278808, createdName=jiyangfei, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=)]
    2020-01-30 daviiliu
  7. [GetPortalCommentsPageByObjectIdResponse(id=1654233, encodeId=5a77165423327, content=<a href='/topic/show?id=58408453394' target=_blank style='color:#2F92EE;'>#脊柱手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84533, encryptionId=58408453394, topicName=脊柱手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63bb24475410, createdName=xuruicheng, createdTime=Tue Mar 31 14:24:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051507, encodeId=3ea2205150e57, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Mar 12 08:24:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633555, encodeId=a54b163355519, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Mon Mar 02 10:24:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1700112, encodeId=de171e0011253, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sat Feb 22 20:24:00 CST 2020, time=2020-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259723, encodeId=cbdb1259e2399, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522669, encodeId=36a81522669bd, content=<a href='/topic/show?id=4c364430828' target=_blank style='color:#2F92EE;'>#失血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44308, encryptionId=4c364430828, topicName=失血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c011466504, createdName=daviiliu, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585698, encodeId=14cb1585698c7, content=<a href='/topic/show?id=e76840556f9' target=_blank style='color:#2F92EE;'>#回顾性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40556, encryptionId=e76840556f9, topicName=回顾性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037917278808, createdName=jiyangfei, createdTime=Thu Jan 30 05:24:00 CST 2020, time=2020-01-30, status=1, ipAttribution=)]

相关资讯

雌性激素有望拯救失血过多患者

阿拉巴马大学伯明翰分校的研究人员们发现雌性激素或许能拯救失血达60%的受伤士兵和失血患者,这是一项突破性的发现。阿拉巴马大学伯明翰分校外科研究中心的主任Irshan Chaudry花了十九年时间来做这个敏感性研究,最近美国国防部与Chaudry签订价值一千万美元的合同,准备开始对合成雌激素(也被称作E2)进行人体临床安全试验。战场上士兵死亡的主要原因是伤口失血过多无法得到处理,而在许多情况下本来可

失血过多时,雌性激素能救命

阿拉巴马大学伯明翰分校的研究人员们发现雌性激素或许能拯救失血达60%的受伤士兵和失血患者,这是一项突破性的发现。阿拉巴马大学伯明翰分校外科研究中心的主任Irshan Chaudry花了十九年时间来做这个敏感性研究,最近美国国防部与Chaudry签订价值一千万美元的合同,准备开始对合成雌激素(也被称作E2)进行人体临床安全试验。 战场上士兵死亡的主要原因是伤口失血过多无法得到处理,而在许多情况下本

病人全身失血近一半 医生在腹腔内做“针线活”止血

高压掉到80mmHg,心率150次/分钟,男子失血性休克……一场紧张的救援也随即展开。

J Orthop Sci:隐性失血影响老年患者围手术期生命安全

在髋部骨折中,股骨转子间骨折髓内固定和股骨颈骨折关节置换术患者围手术期血红蛋白下降水平往往同术中失血量不一致,国外有学者针对此类现象提出“隐性失血”概念,并认为此种巨大变化可能同骨折本身和手术造成的隐性失血相关。 髋部骨折隐性失血的原因目前并不明确,Pattison等专家认为,隐性失血是发生了溶血所致;Mcmanus等专家提出,隐性失血的原因是由于血液大量进入组织间隙,其直接的支持依据是使用

J Arthroplasty:全髋关节置换术,局部 VS.静脉注射氨甲环酸

已知氨甲环酸可减少全髋关节置换术围手术期失血。采用随机对照试验研究设计,共纳入了139名患者,分别接受2 g氨甲环酸局部应用或静脉注射。标准化术前和术后的方案。结果,与局部应用组患者相比 (160.3 [g] ± 63.8, 188.4 [g] ± 68.5; P = .014),静脉注射组患者血液和血红蛋白的损失量较低(1195.0 ± 485.9 mL, 1442.7 ± 562.7 mL;

Blood:ERFE,一种新发现的激素,在红细胞生成过程中的作用。

ERFE是有核红细胞受促红细胞生成素刺激后分泌的一种糖蛋白类激素,可抑制铁调素的表达,从而增加铁的吸收和动员。